Cystic Fibrosis Medication & Lung Function

Trial Objective

We are conducting a research study of an investigational medication that may improve lung function in those patients with CF by treating harmful bacteria, pseudomonas aeruginosa. The study medication uses a portable inhaler and takes less time to administer compared to a nebulized treatment.

Qualifications include:

  • Males and females 18 years of age and older

  • Have a diagnosis of p. aeruginosa within the past 6 months


Study Participation involves:

  • Study related care at no charge

  • Physicals, exams, lab services

  • Active study medication - no placebo

  • Financial compensation for time and travel


This trial is active and currently recruiting.

How to Participate

For more information, contact the study coordinator, Marion Jones, RN at 303.398.1265 or complete the form below.

Who Can Participate

Estimated Time Commitment

Not Specified

Trial Location

National Jewish Main Campus, Denver, CO






Any Gender

Principal Investigators

Request More Information